(Q54424223)

29 May 2018

title

Cross-resistance of nalidixic acid resistant Enterobacteriaceae to new quinolones and other antimicrobials. (English)

1 reference

29 May 2018

0 references

0 references

1

1 reference

29 May 2018

Richard Wise

series ordinal

3

object named as

R Wise

1 reference

29 May 2018

author name string

J M Diver

series ordinal

2

1 reference

29 May 2018

publication date

1 August 1986

1 reference

29 May 2018

European journal of clinical microbiology

published in

1 reference

29 May 2018

volume

5

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

411-415

1 reference

29 May 2018

The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

Role of porin proteins OmpF and OmpC in the permeation of beta-lactams

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

The use of analytical isoelectric focusing for detection and identification of beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

Review of bacterial resistance--a challenge to the treatment of urinary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

In vitro and in vivo activity of DL-8280, a new oxazine derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

In vitro antibacterial activity of AM-715, a new nalidixic acid analog

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02075696

In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents

21 January 2018

1 reference

12 December 2020

Model for regulation of Escherichia coli DNA repair functions

1 reference

12 December 2020

METHOD FOR THE DETECTION OF SIGNIFICANT BACTERIURIA IN LARGE GROUPS OF PATIENTS.

1 reference

12 December 2020

A simple method for the identification of aminoglycoside-modifying enzymes.

1 reference

12 December 2020

Escherichia coli K-12 Mutants Resistant to Nalidixic Acid: Genetic Mapping and Dominance Studies

1 reference

12 December 2020

New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity.

1 reference

12 December 2020

Mutation affecting resistance of Escherichia coli K12 to nalidixic acid.

1 reference

12 December 2020

Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase

1 reference

12 December 2020

Electrophoretic resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

Chemical screening and prediction of bacteriuria--a new approach

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02075696

1 reference

29 May 2018

1 reference

29 May 2018